G
Generate:Biomedicines Tech Stack
AI-powered drug discovery platform using generative biology
Generate:Biomedicines applies machine learning (PyTorch, JAX, TensorFlow) to protein design and therapeutic discovery. The tech stack—spanning analytical chemistry (HPLC, LC-MS), cloud infrastructure (GCP, AWS, Azure), and ML frameworks—reveals a wet-lab-meets-AI model. Hiring velocity is accelerating across research and leadership roles, with active efforts to scale high-throughput screening, biosensor integration, and clinical data infrastructure; pain points around sample-volume reduction and assay scaling suggest the platform is moving from bench science toward automated, AI-driven optimization.
Tech Stack 30 technologies
Core StackSAS AWS Python PostgreSQL Redshift Kubernetes Active Directory Workday NetSuite Terraform GitLab Helm Docker PyTorch TensorFlow NumPy HPLC LC-MS Spotfire GCP Azure AWS ECS macOS Entra E*TRADE Terragrunt Argo CD AWS Secrets Manager JAX SciPy
What Generate:Biomedicines Is Building
◆Challenges
- Risk to timelines or data integrity
- Scaling high-throughput protein assays
- Tech transfer complexity
- Reducing sample volume requirements
- Building investor relations function
- Scaling investor relations
- Establishing scalable ir processes
- Complex biology challenges
- Portfolio balance
- Scalability of pharmacovigilance processes
▲Active Projects
- Late-stage asthma program
- Develop next-generation high-throughput experimental systems
- Clinical data monitoring and safety oversight
- Integrate biosensor technologies with ai design
- High-performing ir operating cadence
- Scalable ir processes
- Conference preparation and execution
- New therapeutic applications enabled by platform
- Cross-functional portfolio execution
- Focused biological strategy
Hiring Activity
25 roles · 25 in 30d
Department
Seniority
Notable leadership hires: Therapeutic Applications Lead, Project Team Lead
Company intelligence
